VIII Gp Limited Partnership Gpe serves as Executive at Syneos Health, Inc., where they oversee executive responsibilities. Since joining the company, VIII Gp Limited Partnership Gpe has executed 7 insider transactions totaling $491.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 12, 2024 involved selling 43,361,053 shares valued at $997.3M.
VIII Gp Limited Partnership Gpe currently holds 56,265,129 shares of Syneos Health, Inc. (SYNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, VIII Gp Limited Partnership Gpe has been a net seller of SYNH stock. They have purchased $0 and sold $491.0M worth of shares.
VIII Gp Limited Partnership Gpe's most recent insider trade was on Mar 12, 2024, when they sold 43,361,053 shares at $23.00 per share.
Get notified when new Form 4 filings are submitted
| $13.37 |
| Discretionary |
| Aug 15, 2022 | SOVO | $113.6M | Sale | 8,500,000 | $13.37 | Discretionary |
| Apr 11, 2022 | CCCS | $39.5M | Sale | 4,258,699 | $9.28 | Discretionary |
| Apr 11, 2022 | CCCS | $119.2M | Sale | 12,841,354 | $9.28 | Discretionary |
| Apr 11, 2022 | CCCS | $3.8M | Sale | 406,142 | $9.28 | Discretionary |
| Dec 3, 2020 | SYNH | $197.8M | Sale | 3,228,241 | $61.28 | Discretionary |